Abstract: New 1-aryl-4-[(aziridine-1-yl)diarylmethyl]-5-methyl-1H-1,2,3-triazole derivatives 7a-i were synthesized by a one-pot reaction of diaryl-(1-aryl-5-methyl-1H-1,2,3-triazol-4-yl)methanols 6a-i derived from 1-aryl-5-methyl-1H-1,2,3-triazole-4-carboxylic acids 4a-c. Structures of compounds 7a-i were confirmed by analysis of proton nuclear magnetic resonance ( 1 H NMR) and carbon-13 nuclear magnetic resonance ( 13 C NMR), mass spectrometry (MS) and infrared (IR) data. The structure of compound 7f was studied by X-ray diffraction analysis. The anticancer activities of compounds 7a-i against human leukemia HL-60 cells and human hepatoma G2 cells were evaluated. Some of the compounds are highly active.
Introduction
A vast majority of biologically important molecules are heterocyclic compounds [1] [2] [3] . The biological properties of aziridine-containing compounds such as azicemicins [4] , miraziridine [5, 6] , azinomycins [7] , ficellomycin [8] , FR-900482 [9] and mitomycins [10] are of significant interest ( Figure 1 ). In particular, mitomycin C has a broad activity against a range of tumors and has been applied clinically since the 1960s. 1,2,3-Triazoles are also pharmacologically important molecules that show anticancer [11] [12] [13] , antibacterial [14, 15] , antifungal [16] , antiviral [17] , anti-inflammatory and analgesic activities [18] (Figure 2 ). However, there is little information describing compounds containing aziridine and 1,2,3-triazole moieties in one molecule. Such compounds are the subject of this report.
Results and discussion
1-Aryl-4-[(aziridin-1-yl)diaryl-methyl]-5-methyl-1H-1,2,3-triazoles 7a-i were synthesized from diaryl-1H-1,2,3-triazol-4-yl) methanols 6a-i. The synthetic route is shown in Scheme 1. Details of the synthesis of compounds 6a-i starting with anilines 1 through intermediaries 4 and 5 were described in our previous report [19] . Structures of products 7a-i were deduced by spectral methods. In particular, a strong absorption at 3320-3520 cm −1 for a hydroxy group, observed in the infrared (IR) spectra of substrates 6a-i, is absent in the IR spectra of products 7a-i. The proton nuclear magnetic resonance ( 
Conclusions
New 1-aryl-4-[(aziridin-1-yl)diaryl-methyl]-5-methyl-1H-1,2,3-triazoles 7a-i were synthesized and their anticancer activities were evaluated. The anticancer activity was investigated under our previously reported conditions [20, 21] using the MTT assay. Compounds 7b,c and 7i are highly active against human leukemia cells and compounds 7c,d, 7f,g inhibit human hepatoma G2 cells.
Experimental
1 H NMR spectra were obtained in deuterated chloroform (CDCl 3 ) at 300 MHz. Starting materials 4-6 were synthesized as previously reported [19] .
Synthesis of compounds 7a-i
Dry hydrogen chloride was bubbled through a hot solution of compounds 6a-i (0.04 mol) in benzene (20 mL) in a 50-mL flask equipped with an automatic water separator, a reflux condenser and a calcium chloride guard-tube. After 1 h, the solution was concentrated to 10 mL and treated with aziridine (0.06 mol) with rapid stirring followed by the addition of triethylamine (0.08 mol). After the mixture was stirred at 45°C for an additional 1 h, the solvent was evaporated and the residue was crystallized from ethyl acetate or purified by column chromatography on silica gel and eluted with ethyl acetate/ petroleum ether. Aziridin-1-yl)-bis(3-chlorophenyl)methyl]-5-methyl-1-p-tolyl-1H-1,2,3 Aziridin-1-yl)-diphenylmethyl]-5-methyl-1-p-tolyl-1H-1,2,3 -1-yl)-diphenylmethyl]-5-methyl-1-phenyl-1H-1,2,3 
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Biological evaluation
The effects of the synthesized compounds on cell viability were investigated under previously reported conditions with human leukemia cells and human hepatoma G2 cells [20, 21] using the MTT assay. 
